stsa Banner

30. LONG-TERM SURVIVAL AND RESOURCE UTILIZATION OF 1,844 PATIENTS UNDERGOING MITRAL VALVE REPLACEMENT: EFFECTS OF CONCOMITANT CORONARY BYPASS SURGERY AND URGENT/EMERGENT OPERATIONS

Vinod H. Thourani, William S. Weintraub, Joseph M. Craver*, Ellis L. Jones*, John Parker Gott*, W. Morris Brown, John D. Puskas, and Robert A. Guyton*

Emory University

Atlanta, Georgia, USA

OBJECTIVE

To evaluate outcomes and resource utilization of 1,844 patients (pts) undergoing mitral valve replacement (MVR) alone or with concomitant coronary artery bypass grafting (MVR/CABG) either electively or urgently/emergently (U/E).

MATERIAL AND METHODS

From January 1980 to December 1997, pts undergoing MVR were subdivided into: (1) MVR (elective, n=1,332), 2) MVR (U/E, n=86), (3) MVR/CABG (elective, n=360), and (4) MVR/CABG (U/E, n=66).

RESULTS

MVR/CABG pts, compared to MVR pts, were significantly older (elective:65± 9, U/E:64± 11 vs elective: 55± 14, U/E:54± 15), were more likely to be males (elective:53%, U/E:62% vs elective:36%, U/E:38%), and had a higher history of HTN (elective:53%, U/E:55% vs elective:24%, U/E:21%), Class III-IV angina (elective:51%, U/E:75% vs elective:18%, U/E:26%) and prior MI (elective:35%, U/E:71% vs elective:7%, U/E:22%). Congestive heart failure was similar among groups (MVR/CABG: elective:62%, U/E:59% vs MVR: elective:63%, U/E:79%, P=0.07). Postoperative morbidity and mortality are included in the Table.

 

MVR

(elective)

MVR

(U/E)

MVR/CABG

(elective)

MVR/CABG

(U/E)

P Value

Q wave MI

5 (0.4%)

0 (0%)

6 (1.7%)

0 (0%)

0.03

Stroke

45 (3.4%)

9 (11.3%)

30 (8.4%)

6 (9.4%)

<0.0001

LOS (days)

11± 9

19± 24

15± 14

16± 18

<0.0001

Hospital Death

77 (5.9%)

16 (20%)

50 (14.0%)

26 (40.6%)

<0.0001

Hospital cost ($)

23,980± 12,339

31,981± 14,170

33,216± 24,132

40,535± 32,465

<0.0001

10-year Survival

0.51

0.46

0.32

0.28

<0.0001

CONCLUSION

The performance of MVR urgently/emergently significantly increases morbidity, mortality and costs compared to elective MVR. Patients undergoing concomitant CABG with elective or urgent/emergent MVR have increased morbidity, mortality, and costs compared to MVR. Careful preoperative scrutiny of the benefit vs resource utilization is required for pts undergoing CABG/MVR or urgent/emergent MVR.

 


STSA 46th Meeting Hyperlinks
Program  Video Session  PGC  1st Session  2nd Session  Th Forum  CV Forum  3rd Session




CTSNet STSA Search Feedback